Press-release for stocks for arrival

Prices are updated after-hours

entities : Arrival source : Www.biospace.com

save search

Will Oral Weight-Loss Drugs Break Open an Already Lucrative Market?
Published: 2024-04-01 (Crawled : 05:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| Email alert Add to watchlist

A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors
Published: 2024-03-25 (Crawled : 13:30) - biospace.com/
URGN | $14.32 0.56% 0.56% 320K

Health Technology

| -9.07% | O: 2.73% H: 12.6% C: 2.9%
ALKS | $23.78 -0.96% -0.97% 1.8M

Health Technology

| -12.94% | O: 0.29% H: 0.71% C: -0.22%

Kenai Emerges from Stealth With $82M Series A, Targets Parkinson’s
Published: 2024-03-01 (Crawled : 17:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| Email alert Add to watchlist
series parkinson’s

MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY
Published: 2024-02-23 (Crawled : 22:00) - biospace.com/
MRNA S | $102.015 -1.38% -1.4% 1.7M

Health Technology

| 4.02% | O: 0.16% H: 1.38% C: -3.15%
mrna construction

PCA 500™-- the world's most efficient and versatile 12-lead ECG, receives FDA clearance for use in acute care
Published: 2024-02-13 (Crawled : 18:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| Email alert Add to watchlist
fda care clearance

Citryll Announces the Appointment of Maarten Kraan as Chief Medical Officer
Published: 2024-02-13 (Crawled : 11:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| Email alert Add to watchlist
medical

Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS
Published: 2024-02-12 (Crawled : 10:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| Email alert Add to watchlist
AMYT | $14.7 0.0% 2.4M

Health Technology

| Email alert Add to watchlist
pharma market

Sensorion Announces a €50.5 Million Financing With Participation From New and Existing US and European Healthcare Specialist Investors
Published: 2024-02-09 (Crawled : 09:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| Email alert Add to watchlist
million specialist

Modivcare Appoints New Chief Commercial Officer and Chief Strategy and Innovation Officer
Published: 2024-01-17 (Crawled : 21:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -46.59% | O: 0.0% H: 0.0% C: 0.0%
MODV 4 | $20.15 -2.94% -3.03% 170K

Health Care and Social Assistan...

| -47.36% | O: -1.75% H: 1.41% C: 0.62%
innovation commercial

Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
Published: 2023-12-05 (Crawled : 15:30) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -57.02% | O: 2.34% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -8.28% | O: 0.72% H: 0.0% C: 0.0%
GOSS 4 | $0.8 -2.44% -2.5% 770K

Health Technology

| -15.37% | O: 1.27% H: 5.99% C: 4.97%
commercial

EmergeOrtho-Triangle Region Welcomes Prominent Anesthesiologist and Pain Management Physician Dr. Robert Baranello
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -53.38% | O: 10.17% H: 0.0% C: 0.0%
management

Almirall Receives European Commission Approval of EBGLYSS® (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis
Published: 2023-11-17 (Crawled : 18:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -52.98% | O: -1.71% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M

Health Technology

| 27.52% | O: 0.49% H: 0.0% C: 0.0%
ebglyss dermatitis approval

Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially ...
Published: 2023-11-10 (Crawled : 23:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -48.1% | O: 0.94% H: 0.0% C: 0.0%
drug

Magenta Medical Reports Positive Results for US Early Feasibility Study of Elevate™ Heart Pump in Providing Temporary Mechanical Circulatory Support During High-Risk PCI Procedures
Published: 2023-10-26 (Crawled : 18:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -45.26% | O: -1.99% H: 0.0% C: 0.0%
positive heart medical results study

QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -49.53% | O: 2.75% H: 0.0% C: 0.0%
QDEL M | $38.28 -1.11% -1.12% 1M

Health Technology

| -44.07% | O: 2.38% H: 0.0% C: -8.35%
results

FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Published: 2023-10-11 (Crawled : 17:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing